Medical Care Technologies Inc. (OTC PINK:MDCE) Nears Completion of AI-Powered App Targeting the $4.5 Billion Global Nutrition & Recipe Market

Rhea-AI Summary

Medical Care Technologies (OTC PINK: MDCE) said its first AI-driven mobile application has entered final development. The app uses image recognition to generate recipes and analyze nutrition from food photos, and the company plans deployment in 175 countries and in 30+ languages.

The release cites industry estimates showing the global diet & nutrition apps market at USD 2.14 billion (2024) projected to USD 4.56 billion (2030), and a recipe app segment forecast to exceed USD 14 billion by 2033. Management frames the consumer app division as a nearer-term revenue path while medical AI work continues and proceeds toward regulatory approval.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MESA, ARIZONA / ACCESS Newswire / October 28, 2025 / Medical Care Technologies Inc. (OTC PINK:MDCE) announced today that its first AI-driven mobile application, [App Name Pending Trademark], has entered its final development phase. The app uses image recognition to create recipes and also analyzes nutrition data directly from food photos. MDCE plans to deploy the app in 175 countries and in over 30 languages.

According to industry research, the global diet & nutrition apps market is valued at approximately USD 2.14 billion in 2024 and projected to reach USD 4.56 billion by 2030, while the recipe app segment may exceed USD 14 billion by 2033 (Grand View Research; Straits Research).

Strategic Positioning: While the company continues to develop its core AI medical applications - which require longer development cycles and regulatory approvals - MDCE's consumer app division is designed to generate revenues more quickly and capture larger addressable markets.

"Our consumer AI launches will complement our ongoing medical technology pipeline," said Marshall Perkins, CEO. "They will likely allow us to build brand presence and revenues while we continue the longer-term path toward regulatory medical AI applications."

About Medical Care Technologies Inc.

Medical Care Technologies Inc. (OTC Pink: MDCE) is a diversified AI technology company innovating across healthcare, collectibles, and digital intelligence. Its subsidiaries Infinite Auctions and Real Game Used drive strong revenue and brand synergy as the company expands its AI applications portfolio. Visit: www.medicalcaretechnologies.com

Safe Harbor Statement:

This press release includes forward-looking statements that involve risks and uncertainties and actual results may differ materially. Risks include but are not limited to international regulatory differences, platform approvals, user adoption, competitive pressures and technology development delays. Medical Care Technologies Inc. assumes no obligation to update any forward-looking statements.

Contact:

Investor Relations
Medical Care Technologies Inc.
info@infiniteauctions.com
Website: www.mdcestock.com

SOURCE: Medical Care Technologies Inc. (OTC PINK:MDCE)

View the original press release on ACCESS Newswire

FAQ

What did Medical Care Technologies (MDCE) announce on October 28, 2025 about its AI app?

MDCE said its first AI-driven mobile app is in final development and uses image recognition to create recipes and analyze nutrition from food photos.

Where and when does MDCE plan to deploy the AI nutrition and recipe app?

MDCE plans global deployment in 175 countries and support in over 30 languages, per the announcement.

How large are the diet & nutrition and recipe app markets cited by MDCE?

The announcement cites industry estimates: diet & nutrition apps at USD 2.14B (2024) to USD 4.56B (2030), and the recipe app segment projecting to over USD 14B by 2033.

Will the MDCE consumer app require regulatory approval before launch?

The company indicated the consumer app targets faster revenue and does not require the longer regulatory cycles described for its medical AI applications.

How does MDCE expect the consumer AI app to affect its broader business strategy?

Management said consumer AI launches are intended to build brand presence and near-term revenues while the medical AI pipeline advances toward regulatory milestones.

Does MDCE provide a commercial launch date or pricing for the app?

No specific launch date or pricing was provided; the company stated the app is in its final development phase.